Primeid Injection (Pridinol Mesylate)

Adult administration

Adults: Inject 2㎎ of pridinol mesylate intramuscularly or intravenously once daily. Adjust the dosage appropriately according to age and symptoms.

This medication should be handled carefully to avoid glass particles when using glass ampoules. Extra caution is required when used in children or the elderly. This medication should not be used in patients with certain diseases. For example, patients allergic to this medication, those with glaucoma, those suffering from urinary difficulties due to prostate enlargement, patients with severe heart disease, patients with intestinal obstruction, patients with megacolon, patients with acute pulmonary edema, tachycardia patients, patients with severe atherosclerosis, and patients with gastrointestinal stenosis should not take this medication. Patients with liver or kidney function issues should be especially cautious when using this medication. Taking this medication may lead to allergic reactions such as skin rash or hives, and rarely, severe allergic reactions may occur. If such symptoms arise, use should be stopped immediately. Additionally, dizziness, staggering, anxiety, and hallucinations may occur, in which case the dosage should be reduced or use should be discontinued. Muscle relaxation or weakness may occur rarely, and gastrointestinal symptoms such as dry mouth, nausea, and vomiting may present. There may be erythema or decreased sweating on the skin, and visual focus problems or glaucoma symptoms may occur. Drowsiness or decreased alertness and reflexes can occur while taking this medication, so driving or operating dangerous machinery should be avoided. Taking this medication with other central nervous system depressants or certain antidepressants can exacerbate side effects, so consulting a doctor is essential. Pregnant women or those who may become pregnant should carefully consider the benefits and risks of taking this medication before use, and breastfeeding women should avoid this medication as it may pass into breast milk. Safety in children has not been sufficiently confirmed, so it should only be used when necessary, and elderly patients should have their dosages reduced due to decreased bodily function. This medication is used as an injection only when oral administration is not possible, and it should be slowly administered after diluting with saline or dextrose solution when given intravenously. Injection should be done with the patient in a lateral position.

• rash
• urticaria
• anaphylactic symptoms
• shock-like symptoms
• dizziness
• staggering
• syncope
• tremors
• anxiety
• hallucinations

This medication is sensitive to light, so it must be stored in a light-blocked sealed container. The recommended storage temperature is between 1 to 30 degrees Celsius at room temperature. This way of storage can help maintain the efficacy and safety of the medication.

Appearance

A colorless and transparent liquid in a brown ampoule for injection

Package unit

1mL x 10 ampoules/box